The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Open accessAbstract
TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by human immunodeficiency virus (HIV)-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm. Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice and several reports indicate that TRIM5 has a role in signal transduction, but the precise mechanism of restriction is unknown. Here we demonstrate that TRIM5 promotes innate immune signalling and that this activity is amplified by retroviral infection and interaction with the capsid lattice. Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13-UEV1A (also known as UBE2N-UBE2V1), TRIM5 catalyses the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (also known as MAP3K7) kinase complex and stimulate AP-1 and NFκB signalling. Interaction with the HIV-1 capsid lattice greatly enhances the UBC13-UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NF-κB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid. Finally, TAK1 and UBC13-UEV1A contribute to capsid-specific restriction by TRIM5. Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signalling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In DCs, TRIM5α binding to the capsid lattice also triggers signal transduction cascades resulting in the activation of the transcription factors AP-1 and NF-κB 59.”
From Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis (2013) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Although this is insufficient to induce IFN production alone, these cascades synergize with other pathways, thus enhancing the IFN response 59.”
From Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis (2013) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M. H., Owens, C. M., Perron, M. J., Kießling, M. K., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,810
Integration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Stremlau, M. H., Perron, M. J., Lee, M. N., Li, Y., Song, B., Javanbakht, H., Diaz‐Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 736
Assembly and Analysis of Conical Models for the HIV-1 Core
Ganser, B. K., Li, S., Klishko, V. Y., Finch, J. T., & Sundquist, W. I. (1999) · Science · doi:10.1126/science.283.5398.80 · Cited by 671
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
Sayah, D. M., Sokolskaja, E., Berthoux, L., & Luban, J. (2004) · Nature · doi:10.1038/nature02777 · Cited by 662
Self-citationAn Atomic Model of the Interferon-β Enhanceosome
Panne, D., Maniatis, T., & Harrison, S. C. (2007) · Cell · doi:10.1016/j.cell.2007.05.019 · Cited by 625
Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., & Chen, Z. J. (2010) · Cell · doi:10.1016/j.cell.2010.03.029 · Cited by 613
Direct activation of protein kinases by unanchored polyubiquitin chains
Xia, Z.-P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature08247 · Cited by 570
X-Ray Structures of the Hexameric Building Block of the HIV Capsid
Pornillos, O., Ganser-Pornillos, B. K., Kelly, B. N., Hua, Y., Whitby, F. G., Stout, C. D., Sundquist, W. I., Hill, C. P., & Yeager, M. (2009) · Cell · doi:10.1016/j.cell.2009.04.063 · Cited by 523
Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee‐Kirsch, M. A., & Lieberman, J. (2010) · Nature Immunology · doi:10.1038/ni.1941 · Cited by 522
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 648
Gong, J., Shen, X., Qiu, H., Chen, C., & Yang, R. (2011) · Archives of Virology · doi:10.1007/s00705-011-1097-6 · Cited by 14
Host–pathogen interaction in HIV infection
Chowdhury, A., & Silvestri, G. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.07.003 · Cited by 16
IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis
Raposo, R. A. S., Rougvie, M. D. M., Paquin‐Proulx, D., Brailey, P. M., Cabido, V. D., Zdinak, P. M., Thomas, A. S., Huang, S.-H., Beckerle, G. A., Jones, R. B., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.85811 · Cited by 13
Herkules, F., Yu, C. H., Taylor, A. B., Dougherty, V., Weintraub, S. T., & Ivanov, D. N. (2022) · Nature Communications · doi:10.1038/s41467-022-34920-3 · Cited by 11
Abortive Infection of Animal Cells: What Goes Wrong
Embry, A., & Gammon, D. B. (2024) · Annual Review of Virology · doi:10.1146/annurev-virology-100422-023037 · Cited by 14
piRNA Defense Against Endogenous Retroviruses
Abajorga, M. K., Yurkovetskiy, L., & Luban, J. (2024) · Viruses · doi:10.3390/v16111756 · Cited by 14
Self-citationAltered antigen-presenting cells during HIV-1 infection
Piguet, V., Caucheteux, S. M., Iannetta, M., & Hosmalin, A. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000096 · Cited by 16
RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction
Marno, K. M., O’Sullivan, E., Jones, C. E., Díaz-Delfín, J., Pardieu, C., Sloan, R. D., & McKnight, Á. (2017) · Journal of Virology · doi:10.1128/jvi.01228-16 · Cited by 13
Das, A., Das, N. D., Jung, K. H., Park, J. H., Lee, H. T., Han, D., Choi, M., Kang, S. C., & Chai, Y. G. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.04.013 · Cited by 13
Trim5 TAKes on Pattern Recognition
Tareen, S. U., & Emerman, M. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.05.003 · Cited by 13
Scott, D., Garner, T. P., Long, J., Strachan, J., Mistry, S. C., Bottrill, A. R., Tooth, D., Searle, M. S., Oldham, N. J., & Layfield, R. (2016) · PROTEOMICS · doi:10.1002/pmic.201600067 · Cited by 13
The p38‐interacting protein p38IP suppresses TCR and LPS signaling by targeting TAK1
Wang, X., Zhao, C.-S., Wang, Q., Zeng, Q., Feng, X., Li, L., Chen, Z., Gong, Y., Han, J., & Li, Y. (2020) · EMBO Reports · doi:10.15252/embr.201948035 · Cited by 13
Mapping of susceptibility loci for Ebola virus pathogenesis in mice
Schäfer, A., Marzi, A., Furuyama, W., Catanzaro, N., Nguyen, C., Haddock, E., Feldmann, F., Meade-White, K. D., Thomas, T., Hubbard, M. L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114127 · Cited by 11
TRIM5 Acts as More Than a Retroviral Restriction Factor
de Silva, S., & Wu, L. J. (2011) · Viruses · doi:10.3390/v3071204 · Cited by 14
Mattiuzzo, G., Rose, N. J., Almond, N. M., Towers, G. J., & Berry, N. J. (2012) · Journal of General Virology · doi:10.1099/vir.0.047795-0 · Cited by 12
Britto, A. M. A., Amoêdo, N. D., Pezzuto, P., Afonso, A. O., de Martínez, A. M. B., Silveira, J. M., Sion, F. S., Machado, E. S., Soares, M. A., & Giannini, A. L. M. (2013) · AIDS · doi:10.1097/qad.0b013e328361cfbf · Cited by 12
Huo, S., Jiao, H., Chen, B., Kuang, M., Li, Q., Lu, Y., & Liu, X. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.04.043 · Cited by 12
Zhang, R., Dai, X., Cao, X., Zhang, C., Wang, K., Huang, X. H., & Ren, Q. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.06.007 · Cited by 12
Editing of the TRIM5 Gene Decreases the Permissiveness of Human T Lymphocytic Cells to HIV-1
Désaulniers, K., Ortiz, L., Dufour, C., Claudel, A., Plourde, M. B., Mérindol, N., & Berthoux, L. (2020) · Viruses · doi:10.3390/v13010024 · Cited by 13
Systems-Biology Approaches to Discover Anti-Viral Effectors of the Human Innate Immune Response
Münk, C., Sommer, A. F. R., & König, R. (2011) · Viruses · doi:10.3390/v3071112 · Cited by 13
Singh, H., Samani, D., Ghate, M., & Gangakhedkar, R. (2017) · The Journal of Gene Medicine · doi:10.1002/jgm.3004 · Cited by 12
Dipalo, L. L., Mikkelsen, J. G., Gijsbers, R., & Carlon, M. S. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.258 · Cited by 12
The recruitment of TRiC chaperonin in rotavirus viroplasms correlates with virus replication
Vetter, J., Papa, G., Tobler, K., Rodríguez, J. M., Kley, M., Myers, M. P., Wiesendanger, M., Schraner, E. M., Luque, D., Burrone, Ó. R., et al. (2024) · mBio · doi:10.1128/mbio.00499-24 · Cited by 11
Dynamic conformational changes in the rhesus TRIM5α dimer dictate the potency of HIV-1 restriction
Lamichhane, R., Mukherjee, S., Smolin, N., Pauszek, R. F., Bradley, M., Sastri, J., Robia, S. L., Millar, D. P., & Campbell, E. M. (2016) · Virology · doi:10.1016/j.virol.2016.10.003 · Cited by 11
Ingram, Z., Fischer, D. K., & Ambrose, Z. (2021) · Viruses · doi:10.3390/v13112237 · Cited by 12
Wu, S., Zhang, J., Xue, Q., Liu, J., Huang, B., He, Z., Huang, J., Zu, S., Chen, Z., Zhao, B., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00377 · Cited by 11
Lentiviral Transduction of Mammary Epithelial Cells
Iggo, R. D., & Richard, É. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2519-3_8 · Cited by 11
Mobasheri, S., Irani, N., Sepahi, A. A., Sakhaee, F., Jamnani, F. R., Vaziri, F., Siadat, S. D., & Fateh, A. (2018) · Gene · doi:10.1016/j.gene.2018.07.023 · Cited by 11
TRIM5 Promotes Systemic Lupus Erythematosus Through CD4(+) T Cells and Macrophage
Pan, Z., Yang, Q., Zhang, X., Xu, X., Sun, Y., Zhou, F., & Wen, L. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s416493 · Cited by 10
Regulation of Mitochondria-Derived Immune Activation by ‘Antiviral’ TRIM Proteins
Oh, S., & Mandell, M. A. (2024) · Viruses · doi:10.3390/v16071161 · Cited by 10
Induction of Autophagy to Achieve a Human Immunodeficiency Virus Type 1 Cure
Campbell, G. R., & Spector, S. A. (2021) · Cells · doi:10.3390/cells10071798 · Cited by 10
Poeschla, E. M. (2013) · Virology · doi:10.1016/j.virol.2013.03.010 · Cited by 12
Tripartite motif‐containing proteins precisely and positively affect host antiviral immune response
Wei, Y., Chen, S., Wang, M., & Cheng, A. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12669 · Cited by 11
The TRIMCyp genotype in four species of macaques in China
Yu, C.-Q., Na, L., Lv, X.-L., Liu, J.-D., Liu, X.-M., Ji, F., Zheng, Y., Du, H.-L., Kong, X.-G., & Zhou, J.-H. (2012) · Immunogenetics · doi:10.1007/s00251-012-0670-9 · Cited by 11
Wei, Y., Zhou, H., Wang, A., Sun, L., Wang, M., Jia, R., Zhu, D., Liu, M., Yang, Q., Wu, Y., et al. (2016) · BioMed Research International · doi:10.1155/2016/1403984 · Cited by 10
Zhou, P., Zhang, Q., Yang, Y., Liu, D., Wu, W., Jongkaewwattana, A., Jin, H., Zhou, H., & Luo, R. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013200 · Cited by 10
Seneca Valley virus 3C protease targets TRIM32 for cleavage to antagonize its antiviral effects
Yang, J., Li, Z., Ma, R., Xie, S., Wang, D., Quan, R., Liu, J., & Song, J. (2025) · Journal of Virology · doi:10.1128/jvi.00590-25 · Cited by 9
Ferguson, D., Mattiuzzo, G., Ham, C., Stebbings, R., Li, B., Rose, N. J., Mee, E. T., Smith, D., Page, M., Cranage, M. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104390 · Cited by 10
Berry, N. J., Mee, E. T., Almond, N. M., & Rose, N. J. (2024) · Microorganisms · doi:10.3390/microorganisms12010155 · Cited by 7
Aiken, C., & Joyce, S. (2011) · Nature · doi:10.1038/472305a · Cited by 9
Insights into Sensing of Murine Retroviruses
Moran, E. A., & Ross, S. R. (2020) · Viruses · doi:10.3390/v12080836 · Cited by 9
Rose, K. M., Spada, S. J., Broeckel, R. M., McNally, K. L., Hirsch, V. M., Best, S. M., & Bouamr, F. (2021) · Viruses · doi:10.3390/v13030446 · Cited by 9
Functions and mechanisms of the Ubc13-UEV complex and lysine 63-linked polyubiquitination in plants
Yang, K., & Xiao, W. (2022) · Journal of Experimental Botany · doi:10.1093/jxb/erac239 · Cited by 9
Human immunodeficiency virus-1 core: The Trojan horse in virus–host interaction
Wang, W., Li, Y., Zhang, Z., & Wei, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1002476 · Cited by 9
Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era
Weatherley, D. A. V., Boswell, M. T., & Rowland‐Jones, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01616 · Cited by 11
Papa, G., Venditti, L., Arnoldi, F., Schraner, E. M., Potgieter, C. A., Borodavka, A., Eichwald, C., & Burrone, Ó. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/660217 · Cited by 9
Huang, L., Zhang, L., Huo, H. J., Hou, J., Niu, M. M., Nie, P., & Chen, S. N. (2023) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2023.104671 · Cited by 8
Miyamoto, T., Nakayama, E. E., Yokoyama, M., Ibe, S., Takehara, S., Kono, K., Yokomaku, Y., Pizzato, M., Luban, J., Sugiura, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047757 · Cited by 8
Self-citationHIV Impairment of Immune Responses in Dendritic Cells
Ahmed, Z., Czubala, M. A., Blanchet, F. P., & Piguet, V. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_8 · Cited by 10
Mohammadzadeh, N., Zhang, N., Branton, W. G., Zghidi‐Abouzid, O., Cohen, É. A., Gelman, B. B., Estaquier, J., Kong, L., & Power, C. (2023) · Viruses · doi:10.3390/v15020316 · Cited by 8
Sun, Q., Han, X., Meng, L., Li, H., Chen, Y., Yin, L., Wang, C., Wang, J., Li, M., Gao, X. M., et al. (2024) · Inflammation · doi:10.1007/s10753-024-01979-7 · Cited by 8
HIV-1 with gag processing defects activates cGAS sensing
Sumner, R. P., Blest, H. T. W., Lin, M., de Motes, C. M., & Towers, G. J. (2024) · Retrovirology · doi:10.1186/s12977-024-00643-0 · Cited by 7
Functional constraints on HIV-1 capsid: their impacts on the viral immune escape potency
Takemura, T., & Murakami, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00369 · Cited by 8
Calonge, E., Bermejo, M., Díez‐Fuertes, F., Mangeot, I., Gonzàlez, N., Coiras, M., Tormo, L. J., García‐Pérez, J., Dereuddre‐Bosquet, N., Grand, R. L., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01379-16 · Cited by 8
Biochemical strategies of E3 ubiquitin ligases target viruses in critical diseases
Dubey, A. R., Jagtap, Y. A., Kumar, P., Patwa, S. M., Kinger, S., Kumar, A., Singh, S., Prasad, A., Jana, N. R., & Mishra, A. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30143 · Cited by 8
Lentiviral Transduction of Mammary Epithelial Cells
Iggo, R. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2193-6_8 · Cited by 8
Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor
Twentyman, J., Khalifeh, A., Felton, A., Emerman, M., & OhAinle, M. (2023) · Retrovirology · doi:10.1186/s12977-023-00629-4 · Cited by 8
Interactions Between HIV-1 and Innate Immunity in Dendritic Cells
Silvin, A., & Manel, N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_7 · Cited by 11
The Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV?
Schaller, T., & Herold, N. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094914 · Cited by 8
Rhesus monkey TRIM5α protein SPRY domain contributes to AP-1 activation
Na, L., Tang, Y.-D., Wang, C., Liu, C., & Wang, X. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000127 · Cited by 8
Direct activation of an innate immune system in bacteria by a viral capsid proteinPreprint
Zhang, T., Tamman, H., Wallant, K. C. ’., Kurata, T., LeRoux, M., Srikant, S., Brodiazhenko, T., Čepauskas, A., Talavera, A., Martens, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.30.493996 · Cited by 8
Zhao, C., Peng, C., Wang, P., Zhang, B., Yan, L. E., Wang, C., & Qiu, L. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108940 · Cited by 6
Toll-like receptor (TLR) 3 as a surrogate sensor of retroviral infection in human cells
Miyauchi, K., Urano, E., Takeda, S., Murakami, T., Okada, Y., Cheng, K., Yin, H. H., Kubo, M., & Komano, J. A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.148 · Cited by 6
Using TRIM5α as an HIV therapeutic: the alpha gene?
Anderson, J. S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.779251 · Cited by 8
Krieger, J., Riedl, P., Stifter, K., Román‐Sosa, G., Seufferlein, T. T. W., Wagner, M., & Schirmbeck, R. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.011 · Cited by 7
Peng, C., Zhao, C., Wang, P., Yan, L. E., Fan, S., & Qiu, L. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.02.002 · Cited by 7
Hadpech, S., Moonmuang, S., Chupradit, K., Yasamut, U., & Tayapiwatana, C. (2021) · Intervirology · doi:10.1159/000519241 · Cited by 8
Gack, M. U. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.08.012 · Cited by 7
Fv1 Restriction and Retrovirus Vaccine Immunity in Apobec3-Deficient 129P2 Mice
Halemano, K., Barrett, B. S., Li, S. X., Harper, M. S., Smith, D. S., Heilman, K. J., & Santiago, M. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060500 · Cited by 7
Çevik, M., & Orkin, C. M. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1692811 · Cited by 7
TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling
Grütter, M. G., & Luban, J. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.02.003 · Cited by 137
Self-citationThe Involvement of Ubiquitination and SUMOylation in Retroviruses Infection and Latency
Liang, T., Li, G., Lu, Y., Hu, M., & Ma, X. (2023) · Viruses · doi:10.3390/v15040985 · Cited by 6
TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity
Spada, S. J., Grigg, M. E., Bouamr, F., Best, S. M., & Zhang, P. (2024) · Viruses · doi:10.3390/v16070997 · Cited by 5
Wei, Y., Song, J., Zhang, J., Chen, S., Yu, Z., He, L., & Chen, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1420854 · Cited by 6
Cyclophilin A Regulates Tripartite Motif 5 Alpha Restriction of HIV-1
Wang, T., Becker, D., Twizerimana, A. P., Luedde, T., Gohlke, H., & Münk, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020495 · Cited by 6
The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replication
Kuang, Y., Liu, H., & Zheng, Y. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0417-y · Cited by 6
Mapping Viral Susceptibility Loci in Mice
Kane, M., & Golovkina, T. V. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015544 · Cited by 6
Luckett‐Chastain, L. R., King, C. J., McShan, W. M., Gipson, J. R., Gillaspy, A. F., & Gallucci, R. M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.658980 · Cited by 6
Help or Hinder: Protein Host Factors That Impact HIV-1 Replication
Moezpoor, M. R., & Stevenson, M. (2024) · Viruses · doi:10.3390/v16081281 · Cited by 7
Not so unique to Primates: The independent adaptive evolution of TRIM5 in Lagomorpha lineage
Águeda-Pinto, A., de Matos, A. L., Pinheiro, A., Neves, F., de Sousa-Pereira, P., & Esteves, P. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226202 · Cited by 6
Chistiakov, D. A., Grechko, A. V., Orekhov, A. N., & Bobryshev, Y. V. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.34 · Cited by 6
Hu, P., Hao, Y., Tang, W. H., Diering, G. H., Zou, F., & Kafri, T. (2025) · Viruses · doi:10.3390/v17020276 · Cited by 5
Fang, H., Wu, X. M., Zheng, S. Y., & Chang, M. X. (2024) · Journal of Virology · doi:10.1128/jvi.00158-24 · Cited by 5
Broad Utility of an Affinity-enrichment Strategy for Unanchored Polyubiquitin Chains
Shaw, B. (2014) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.s7-001 · Cited by 5
Beyond Impairment of Virion Infectivity: New Activities of the Anti-HIV Host Cell Factor SERINC5
Ahmed, S. S., Bajak, K., & Fackler, O. (2024) · Viruses · doi:10.3390/v16020284 · Cited by 5
HIV-1 Structural Proteins or Cell-Signaling Factors? That Is the Question!
PELLEGRINO, M. A., Giordano, F., Amicis, F. D., Marra, M., Tucci, P., Marsico, S., & Aquaro, S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060306 · Cited by 5
Lei, N., Tang, Y.-D., Liu, J., Yu, C., Sun, L., Lin, Y., Wang, X., Wang, X., & Zhou, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.132 · Cited by 5
Role of Innate Genes in HIV Replication
Schott, K., Rieß, M., & König, R. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_29 · Cited by 5
Retrovirus Restriction by TRIM5α: RINGside at a Cage Fight
Sundquist, W. I., & Pornillos, O. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.11.013 · Cited by 5
Sauter, M. M., & Brandt, C. R. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108436 · Cited by 5
HIV Restriction Factors and Their Ambiguous Role during Infection
Zotova, A., Atemasova, A., Filatov, A. V., & Mazurov, D. V. (2019) · Molecular Biology · doi:10.1134/s0026893319020171 · Cited by 5
Ye, S., Wu, L., Luo, M., Xu, T., & Wu, X. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.03.350 · Cited by 5
Potent restriction of HIV-1 and SIVmac239 Replication by African Green Monkey TRIM5α
Coren, L. V., Trivett, M. T., Jain, S., Ayala, V. I., Prete, G. Q. D., Öhlén, C., & Ott, D. E. (2015) · Retrovirology · doi:10.1186/s12977-015-0137-9 · Cited by 6
Rigano, A., Galli, V., Clark, J., Pereira, L. E., Grossi, L., Luban, J., Giulietti, R., Leidi, T., Hunter, E., Valle, M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/251850 · Cited by 4
Self-citationRui, D., Zhu, S.-H., Yao, T.-S., & Zhang, H. (2025) · Measurement · doi:10.1016/j.measurement.2025.118747 · Cited by 4
Cannac, M., Zoladek, J., Bribes, I., Fresneau--Resende, M., Legrand, A., Demeure, R., Žusinaite, E., Merits, A., Etienne, L., & Nisole, S. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013773 · Cited by 4
Uthirapathy, S., Ahmed, A. T., Jawad, M. J., Jain, V. D., Ballal, S., Al‐Hetty, H. R. A. K., Khandelwal, G., Arya, R., Kariem, M., & Mustafa, Y. F. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114379 · Cited by 4
Hage, A., Janes, M., & Best, S. M. (2025) · Viruses · doi:10.3390/v17040562 · Cited by 4
Liu, F., Kuang, Y., Mu, D., Zheng, H., Zhu, J. W., & Zheng, Y. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121666 · Cited by 4
Polyubiquitin chain-dependent protein degradation in TRIM30 cytoplasmic bodies
Choi, U. Y., Choi, W. Y., Hur, J. Y., & Kim, Y.-J. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.12 · Cited by 4
Metadata
- Authors
- Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., Bisiaux, A., Albert, M. L., Strambio-De-Castillia, C., Mothes, W., Pizzato, M., Grütter, M. G., & Luban, J.
- Affiliations
- University of Geneva (CH)
- University of Zurich (CH)
- Yale University (US)
- Light Chain Bioscience (Switzerland) (CH)
- Inserm (FR)
- Corresponding author
- Luban, Jeremy
- ORCID
- Venue
- Nature
- Published
- 2011-04
- Volume
- 472
- Issue
- 7343
- Pages
- 361-365
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3081621
- OpenAlex
- W2057040546
- Cited by
- 645
- References
- 27
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 35 · 2023: 27 · 2022: 19 · 2021: 34 · 2020: 39 · 2019: 50 · 2018: 43 · 2017: 41 · 2016: 39 · 2015: 48 · 2014: 56 · 2013: 70 · 2012: 72
- FWCI
- 29.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- SERVAL (Université de Lausanne) (acceptedVersion, other-oa)
- IRIS (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (59159, 128655, 122342, 3100A0)
- National Institutes of Health (3100A0-128655)
- National Institute of Allergy and Infectious Diseases (R01 AI59159, R01AI059159, R21AI087467)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TRIM5, antiretroviral restriction factors, E3 ubiquitin ligase, pattern recognition receptors, innate immune signaling, K63-linked ubiquitin, TAK1, NF-κB signaling, retroviral infection
- MeSH terms
- Tripartite Motif Proteins, Antiviral Restriction Factors, MAP Kinase Kinase Kinase 7, Capsid, Carrier Proteins, Cell Line, Enzyme Activation, Humans, Immunity, Innate, Lipopolysaccharides, Protein Binding, Retroviridae, Transcription Factors, Signal Transduction, HIV-1, NF-kappa B, Transcription Factor AP-1, MAP Kinase Kinase Kinases, Ubiquitin, Ubiquitin-Conjugating Enzymes, Ubiquitin-Protein Ligases, Receptors, Pattern Recognition, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review